GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CeriBell Inc (NAS:CBLL) » Definitions » Net Income From Continuing Operations

CBLL (CeriBell) Net Income From Continuing Operations : $-44.71 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is CeriBell Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. CeriBell's net income from continuing operations for the three months ended in Mar. 2025 was $-12.78 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2025 was $-44.71 Mil.

CeriBell Net Income From Continuing Operations Historical Data

The historical data trend for CeriBell's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CeriBell Net Income From Continuing Operations Chart

CeriBell Annual Data
Trend Dec22 Dec23 Dec24
Net Income From Continuing Operations
-37.16 -29.46 -40.46

CeriBell Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income From Continuing Operations Get a 7-Day Free Trial -8.52 -8.94 -10.42 -12.58 -12.78

CeriBell Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-44.71 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CeriBell Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CeriBell Inc (NAS:CBLL) » Definitions » Net Income From Continuing Operations
Comparable Companies
TANAF NPCE BBNX AVNS RXST DCTH IRMD BFLY KIDS AXGN ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD
Traded in Other Exchanges
N/A
Address
360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085
Website
https://www.ceribell.com
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.